About this opportunity
AI summaryThe buyer seeks Atropine Injection, 2 mg per 0.7 mL, provided in a pressure-activated automatic injector suitable for rapid intramuscular administration under NDA No. 212319. The auto-injectors must meet strict chemical, sterile, physical, and packaging specifications, delivering 1.67 mg atropine base within 0.5 seconds, with a minimum of 24 months of shelf life remaining at the time of delivery. The provided document excerpts do not specify eligible applicants, submission deadlines, question deadlines, proposal evaluation criteria, contract terms, or budget details.
Scope of work
- Atropine Injection 2 mg in pressure-activated automatic injectors
- Individual unit packaging in polyethylene sealed bags
- Intermediate packaging containing forty individually packaged auto-injectors per box
- Exterior shipping containers packing twelve intermediate packages for 480 units total
- Certificate of sterility listing all lot numbers and compliance testing results
- Retention samples for stability testing as per current CGMP requirements
Minimum qualifications
- Manufacturing in certified facility in accordance with approved NDA No. 212319
- Compliance with Federal Food, Drug and Cosmetic Act and applicable Federal, State, and local statutes
- Compliance of all ingredients with compendial standards USP/NF in accordance with approved NDA No. 212319
Documents to include with your response
- Certificate of sterility
Contract details
- Funding
- Federal Acquisition Regulation Subpart 23.4
Federal notice details
- Solicitation number
- SPE2DP-27-R-ATRO
- Agency
- Department of Defense
- Buying office
- Defense Logistics Agency › DLA Troop Support
- Notice type
- Sources Sought
- Responses due
- Nov 30, 2026, 11:59 PM ET
- Posted on SAM.gov
- Oct 29, 2026
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product/service code
- 6505
- Set-aside
- No Set aside used
- Place of performance
- Philadelphia, PA, 19111
- Contracting contact
- Alec Deichman
alec.deichman@dla.mil
445-737-5743 - Additional contact
- Jessica De La Hoz
jessica.delahoz@dla.mil
4457373623
Source: SAM.gov. Read the official notice for the complete description and current instructions.
Incumbent and award research
No incumbent history found for this requirement. The notice does not cite a current contract, and no earlier award from this buying office matches it.
Market context
Awards in the same category (Pharmaceutical Preparation Manufacturing). This is not this requirement's award history.
Recent similar awards: Department of Defense, NAICS 325412, performed in PA
| Vendor and award | Value | Ends |
|---|---|---|
| THE STRONGHOLD GROUP LLCSPE2DP26P1052 · 8512253365!PRUSSIAN BLUE CAPSU | $35,772 | Aug 21, 2026 |
| THE STRONGHOLD GROUP LLCSPE2DP26P1033 · 8512245571!PRUSSIAN BLUE CAPSU | $52,272 | Aug 21, 2026 |
| SANOFI VACCINES US INC.SPE2DP25P0505 · 8511453063!TYPHOID VI POLYSACC | $221.4K | Jul 8, 2025 |
| SANOFI VACCINES US INC.SPE2DP23P0627 · 8509999551!YELLOW FEVER VACCIN | $25,198 | Jul 25, 2023 |
| SANOFI VACCINES US INC.W912L723F0021 · POLIOVIRUS, DIPHTHERIA, TYPHOID VACCINES FOR TNARNG. | $34,122 | Jun 17, 2023 |
Top vendors in this category: Department of Defense, NAICS 325412, since Oct 1, 2024
34,350 contract awards in this NAICS over the period.
- 1. TEVA PHARMACEUTICALS USA, INC.$75.2M
- 2. CANADIAN COMMERCIAL CORPORATION$31.8M
- 3. CARDINAL HEALTH 414, LLC$7.3M
- 4. NOVARTIS PHARMACEUTICALS CORPORATION$5.1M
- 5. DMS PHARMACEUTICAL GROUP INC$4.1M
Source: USAspending.gov federal award data (U.S. federal public data). A contract is called the incumbent only when the notice or its documents cite it by number.